ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 곤충 세포 배양 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 17억 8,000만 달러에서 2025년에는 19억 7,000만 달러로, CAGR 10.8%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 생물학적 제제에 대한 수요 증가, 재조합 단백질 생산의 보급 확대, 유전자 치료에서 바이러스 벡터의 사용 증가, 백신 제조의 확대, 첨단 치료법에 대한 관심 증가에 기인한다고 생각됩니다.
곤충 세포 배양 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년까지 29억 4,000만 달러에 달하고, CAGR은 10.5%가 될 전망입니다. 예측 기간의 성장은 유전자 치료에 대한 수요 증가, 바이오 의약품 제조에 대한 투자 확대, 바이오시밀러 채용 확대, CRO(수탁 연구 기관)의 확대, 맞춤형 의료에 대한 주목 증가에 기인하는 것으로 예측됩니다. 예측 기간에 예상되는 주요 동향은 세포 배양 시스템의 기술적 진보, 단일 세포 클로닝 및 추적성의 혁신, 화학적으로 정의된 배지에서의 연구 개발, 현탁 배양 기술의 진전, 확장 가능한 바이오프로세싱 플랫폼의 진보를 포함합니다.
감염 증가 추세는 향후 몇 년 동안 곤충 세포 배양 시장의 성장을 가속할 것으로 예측됩니다. 감염은 박테리아, 바이러스, 곰팡이, 기생충과 같은 미생물로 인한 질병으로, 인간에서 인간으로, 동물에서 인간으로, 또는 오염된 식품, 물, 환경원을 통해 직접 또는 간접적으로 전파될 수 있습니다. 전염병 증가는 세계 이동 증가에 의해 촉진되고, 이로써 병원체가 지역과 집단을 넘어 더 빠르게 전파될 수 있습니다. 곤충 세포 배양은 백신, 바이러스 벡터, 재조합 단백질의 효율적인 생산을 가능하게 하고, 예방 및 치료 솔루션 개발을 위한 안전하고 확장 가능한 플랫폼을 제공함으로써 감염증 대책에 기여합니다. 예를 들어 영국 공중보건청(UKHSA)의 발표에 따르면 2025년 3월 시점에서 영국의 결핵증례 수는 2024년에 전년대비 13% 증가하여 5,480건(2023년은 4,850건)에 달했습니다. 이것은 현저한 증가 경향을 보여줍니다. 이 결과, 감염증의 만연 확대가 곤충 세포 배양 시장의 성장을 견인하고 있습니다.
곤충 세포 배양 시장의 주요 기업은 제품의 일관성 향상, 바이오프로세싱 효율의 강화, 첨단 생물학적 제제 및 유전자 치료 용도에서의 규제 준수를 확보하기 위해 단일 세포 클로닝 및 추적성 등 세포 배양 기술의 혁신에 주력하고 있습니다. 단일 세포 클로닝 및 추적성은 개별 세포를 분리하여 유전적으로 균일한 세포주를 생성하는 동시에 기원, 취급 및 이력에 대한 완전한 문서화를 유지하고 재현성, 품질 관리 및 규제 준수를 보장하는 프로세스입니다. 예를 들어, 2023년 6월에는 세포 배양 배지를 전문으로 하는 미국 기업 Expression Systems가 조사 용도에 대한 조기 액세스 제공을 시작한 'sf9 rv-free' 곤충 세포주를 발표했습니다. 이 랩도바이러스가 없는 세포주는 현탁 배양에서 증식하고, ESF의 첨단 화학 정의 곤충 세포 배양 배지에 최적화되어 5일간 급속한 증식, 95% 이상의 생존율, 고세포 밀도를 달성합니다. 본 세포주는 재조합 단백질, 아데노 관련 바이러스(AAV), 바이러스 유사 입자(VLP)의 생산에 적합하며, 유전자 치료 및 바이러스 백신 응용을 지원합니다. 단일 세포 프린트 기술을 사용하여 복제되고 완전한 프로토콜, 추적성 및 규제 관련 문서가 함께 제공됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 곤충 세포 배양 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 곤충 세포 배양 시장 : 성장률 분석
세계의 곤충 세포 배양 시장 실적 : 규모와 성장, 2019-2024년
세계의 곤충 세포 배양 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 곤충 세포 배양 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 곤충 세포 배양 시장 : 제품 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
배지
시약
혈청
기기
세계의 곤충 세포 배양 시장 : 세포 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
S19(스포도프테라 프루기페르다)
하이파이브(트리코프루시아 니)
Sf21(스포도프테라 프루기페르다)
초파리 슈나이더 2(s2)
세계의 곤충 세포 배양 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
바이오 의약품 제조
유전자 치료
조직 배양 및 조직 공학
세포유전학
세계의 곤충 세포 배양 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제약 및 바이오테크놀러지 기업
학술연구기관
수탁연구기관
세계의 곤충 세포 배양 시장 : 배지 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
배양 배지
무혈청 배지
무단백 배지
화학적으로 정의된 배지
특수 배지
맞춤형 배지 조성
세계의 곤충 세포 배양 시장 : 시약 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
흡착인자
분리 시약
완충액 및 염류
동결보호제
항생제 및 항진균제
트랜스펙션 시약
보충품
세계의 곤충 세포 배양 시장 : 혈청 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
소 태아 혈청(FBS)
곤충 유래 혈청
하이브리도마 혈청
혈청 대체품
열 비활성화 혈청
세계의 곤충 세포 배양 시장 : 기기 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
바이오리액터
세포 배양 플라스크 및 플레이트
셰이커 및 인큐베이터
원심분리기
현미경 및 영상 시스템
여과 시스템
자동 세포 계수 장치
극저온 보존 시스템
제7장 지역별/국가별 분석
세계의 곤충 세포 배양 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 곤충 세포 배양 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
곤충 세포 배양 시장 : 경쟁 구도
곤충 세포 배양 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Danaher Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
GE Healthcare : 개요, 제품 및 서비스, 전략 및 재무 분석
Becton, Dickinson and Company : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Corning Incorporated
Lonza Group Ltd.
Charles River Laboratories
Sartorius AG
wuxi biologics
QIAGEN NV
Eppendorf AG
Novavax Inc.
Takara Bio Inc.
GenScript Biotech Corporation
Promega Corporation
HiMedia Laboratories Pvt. Ltd.
Cell Culture Company
Trenzyme
Proteogenix
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
곤충 세포 배양 시장(2029년) : 새로운 기회를 제공하는 국가
곤충 세포 배양 시장(2029년) : 새로운 기회를 제공하는 부문
곤충 세포 배양 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Insect cell culture is a laboratory method in which cells derived from insects are grown and sustained under controlled conditions outside their natural environment. These cultures offer a flexible platform for producing recombinant proteins, vaccines, and viral vectors because of their ability to perform complex post-translational modifications. They are widely used in research and biopharmaceutical manufacturing due to their capacity to efficiently support viral replication and protein expression.
The key product types used in insect cell culture include media, reagents, sera, and equipment. Media refers to nutrient-rich formulations designed to support the growth, maintenance, and productivity of insect cells in both laboratory and industrial settings. Key cell types include S19 (Spodoptera frugiperda), High Five (Trichoplusia ni), Sf21 (Spodoptera frugiperda), and Drosophila Schneider 2 (S2). Major applications encompass biopharmaceutical manufacturing, gene therapy, tissue culture and engineering, and cytogenetic studies, with primary end users including pharmaceutical and biotechnology companies, academic and research institutions, and contract research organizations.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The insect cell culture market research report is one of a series of new reports from The Business Research Company that provides insect cell culture market statistics, including the insect cell culture industry global market size, regional shares, competitors with the insect cell culture market share, detailed insect cell culture market segments, market trends, and opportunities, and any further data you may need to thrive in the insect cell culture industry. This insect cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The insect cell culture market size has grown rapidly in recent years. It will grow from $1.78 billion in 2024 to $1.97 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. Growth during the historic period can be attributed to increasing demand for biologics, wider adoption of recombinant protein production, rising use of viral vectors in gene therapy, expansion of vaccine manufacturing, and a growing focus on advanced therapies.
The insect cell culture market size is expected to see rapid growth in the next few years. It will grow to $2.94 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. Growth in the forecast period can be attributed to rising demand for gene therapy, increased investments in biopharmaceutical manufacturing, greater adoption of biosimilars, the expansion of contract research organizations, and a stronger focus on personalized medicine. Major trends expected in the forecast period include technological advancements in cell culture systems, innovations in single-cell cloning and traceability, research and development in chemically defined media, progress in suspension culture techniques, and advancements in scalable bioprocessing platforms.
The rising prevalence of infectious diseases is expected to drive the growth of the insect cell culture market in the coming years. Infectious diseases are disorders caused by microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from person to person, from animals to humans, or through contaminated food, water, or environmental sources. The increase in infectious diseases is fueled by greater global travel, which allows faster transmission of pathogens across regions and populations. Insect cell culture helps address infectious diseases by enabling the efficient production of vaccines, viral vectors, and recombinant proteins, providing a safe and scalable platform for developing preventive and therapeutic solutions. For example, in March 2025, according to the UK Health Security Agency (UKHSA), a UK-based government organization responsible for protecting public health and preparing for infectious disease threats, tuberculosis cases in England increased by 13 percent in 2024 to 5,480, up from 4,850 in 2023, indicating a notable year-over-year rise. Consequently, the rising prevalence of infectious diseases is driving growth in the insect cell culture market.
Leading companies in the insect cell culture market are focusing on innovation in cell culture technology, such as single-cell cloning and traceability, to improve product consistency, enhance bioprocessing efficiency, and ensure regulatory compliance for advanced biologics and gene therapy applications. Single-cell cloning and traceability is a process in which individual cells are isolated to create genetically uniform cell lines while maintaining complete documentation of their origin, handling, and history, ensuring reproducibility, quality control, and regulatory compliance. For example, in June 2023, Expression Systems, a US-based company specializing in cell culture media, launched the sf9 rv-free insect cell line with early-access availability for research use. This rhabdovirus-free cell line, grown in suspension, is optimized for ESF advanced chemically defined insect cell culture medium, achieving rapid growth, over 95 percent viability, and high cell densities within five days. It is suitable for producing recombinant proteins, adeno-associated viruses (AAV), and virus-like particles (VLPs), supporting gene therapy and viral vaccine applications. The cells are cloned via single-cell printing and come with full protocols, traceability, and regulatory documentation.
In April 2024, Sino Biological Inc., a China-based biotechnology company, acquired SignalChem Biotech Inc. for $48 million. Through this acquisition, Sino Biological aims to strengthen its global presence, expand its product portfolio in kinase-related research reagents, and enhance capabilities in drug discovery and development support. SignalChem Biotech Inc. is a Canada-based biotechnology company focused on producing bioactive enzymes, signaling proteins, and other molecular tools for cancer research, cell signaling studies, and therapeutic development.
Major companies operating in the insect cell culture market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Becton, Dickinson and Company, Corning Incorporated, Lonza Group Ltd., Charles River Laboratories, Sartorius AG, Wuxi Biologics, QIAGEN N.V., Eppendorf AG, Novavax Inc., Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, HiMedia Laboratories Pvt. Ltd., Cell Culture Company, Trenzyme, Proteogenix.
Asia-Pacific was the largest region in the insect cell culture market in 2024, and it is expected to be the fastest-growing region in the forecast period. The regions covered in insect cell culture report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the insect cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The insect cell culture market consists of sales of media, reagents, sera, equipment, bioreactors, flasks, incubators, centrifuges, pipettes, filters, culture plates, shakers, and microscopes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Insect Cell Culture Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on insect cell culture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for insect cell culture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The insect cell culture market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Media; Reagents; Sera; Equipment
2) By Cell Type: S19 (Spodoptera Frugiperda); High Five (Trichoplusia Ni); Sf21 (Spodoptera Frugiperda); Drosophila Schneider 2 (s2)
3) By Application: Biopharmaceutical Manufacturing; Gene Therapy; Tissue Culture And Engineering; Cytogenetic
4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations
Subsegments:
1) By Media: Growth Media; Serum-Free Media; Protein-Free Media; Chemically Defined Media; Specialty Media; Custom Media Formulations
2) By Reagents: Attachment Factors; Dissociation Reagents; Buffers And Salts; Cryoprotectants; Antibiotics And Antimycotics; Transfection Reagents; Supplements
4) By Equipment: Bioreactors; Cell Culture Flasks And Plates; Shakers And Incubators; Centrifuges; Microscopes And Imaging Systems; Filtration Systems; Automated Cell Counters; Cryogenic Storage Systems
Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; GE Healthcare; Becton, Dickinson and Company; Corning Incorporated; Lonza Group Ltd.; Charles River Laboratories; Sartorius AG; Wuxi Biologics; QIAGEN N.V.; Eppendorf AG; Novavax Inc.; Takara Bio Inc.; GenScript Biotech Corporation; Promega Corporation; HiMedia Laboratories Pvt. Ltd.; Cell Culture Company; Trenzyme; Proteogenix.
Countries:
Table of Contents
1. Executive Summary
2. Insect Cell Culture Market Characteristics
3. Insect Cell Culture Market Trends And Strategies
4. Insect Cell Culture Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Insect Cell Culture Growth Analysis And Strategic Analysis Framework
5.1. Global Insect Cell Culture PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Insect Cell Culture Market Growth Rate Analysis
5.4. Global Insect Cell Culture Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Insect Cell Culture Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Insect Cell Culture Total Addressable Market (TAM)
6. Insect Cell Culture Market Segmentation
6.1. Global Insect Cell Culture Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Media
Reagents
Sera
Equipment
6.2. Global Insect Cell Culture Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
S19 (Spodoptera Frugiperda)
High Five (Trichoplusia Ni)
Sf21 (Spodoptera Frugiperda)
Drosophila Schneider 2 (s2)
6.3. Global Insect Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biopharmaceutical Manufacturing
Gene Therapy
Tissue Culture And Engineering
Cytogenetic
6.4. Global Insect Cell Culture Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic And Research Institutes
Contract Research Organizations
6.5. Global Insect Cell Culture Market, Sub-Segmentation Of Media, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Growth Media
Serum-Free Media
Protein-Free Media
Chemically Defined Media
Specialty Media
Custom Media Formulations
6.6. Global Insect Cell Culture Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Attachment Factors
Dissociation Reagents
Buffers And Salts
Cryoprotectants
Antibiotics And Antimycotics
Transfection Reagents
Supplements
6.7. Global Insect Cell Culture Market, Sub-Segmentation Of Sera, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fetal Bovine Serum (FBS)
Insect-Derived Serum
Hybridoma Serum
Serum Substitutes
Heat-Inactivated Serum
6.8. Global Insect Cell Culture Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bioreactors
Cell Culture Flasks And Plates
Shakers And Incubators
Centrifuges
Microscopes And Imaging Systems
Filtration Systems
Automated Cell Counters
Cryogenic Storage Systems
7. Insect Cell Culture Market Regional And Country Analysis
7.1. Global Insect Cell Culture Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Insect Cell Culture Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
